SOPH

SOPH

USD

SOPHiA GENETICS SA Ordinary Shares

$4.680-0.140 (-2.905%)

Real-time Price

Healthcare
Health Information Services
Switzerland

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$4.820

High

$5.110

Low

$4.630

Volume

0.18M

Company Fundamentals

Market Cap

316.3M

Industry

Health Information Services

Country

Switzerland

Trading Stats

Avg Volume

0.09M

Exchange

NMS

Currency

USD

52-Week Range

Low $2.58Current $4.680High $5.3

Related News

Analyst Upgrades

BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $7

BTIG analyst Mark Massaro maintains Sophia Genetics with a Buy and raises the price target from $6 to $7.

View more
BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $7
PR Newswire

SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance

SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the third quarter ended...

View more
SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance
GlobeNewswire

Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

Highlights Third quarter 2025 revenue of $205.7 million decreased by 4% year-over-year but was flat when excluding previously discussed headwinds1 of $8.1 million, consistent with management expectations.Third quarter

View more
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
PR Newswire

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025

SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the third...

View more
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025